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Editorial
Obesity (BMI > or = 30) rated as the second leading cause
of death and an increasing socioeconomic burden such a public
related aspects with a mortality rate that is likely 2.6 million people
each year according to WHO. Obesity contributes to metabolic
disorders causing imbalanced energy combined with genetic defects
including the brain reward circuit and metabolic impairment [14]. The prevalence of obesity may associate with environmental
chemical exposure, which affects fat mass and adipogenesis in the
United States [5]. However, it is poorly understood that the effects of
several factors, for example, a wide range of stresses and medical over
usage such as birth control pills, antidepressants, and antipsychotics
reflects tissue damage and intervenes with the neuronal circuit due
to evoked oxidative stress resulting from the interaction between
macromolecules such as DNA, lipid and protein. Also including a
wide range of environmental factors such as chemical ingredients
found in a variety of foods and overburden stresses like the absence
of smoking, pregnancy, menopause, sleeping disorder, anxiety, and
respiratory problems which occur in everyday life. In addition, some
reports indicate that obesity is associated with brain disorder like
as malfunction of brain reward system against stimulatory impulse
or responses. The mechanism underlying the molecular “trigger”
for prevention and therapy in prominent metabolic disorder such
as Obese and diabetes still remains to be a mystery. Interestingly,
there are many evidences to support interaction between obesity and
several types of disorders for example, dysglycemia, dyslipidemia,
CVD, stroke, hypertension, and cancer including endometrial,
breast, prostate, colon, and GI cancer [6-12]. Advent of Cutting edge
knowledge derived from system biology and integration of genomics
study such as GWAS and NGS- based detection tools can apply to
diagnose and predict diseases status using clinic samples which
may contain multilayer formulated macromolecules from patients.
Both analytical tools could be optimized for precision of medicine
for obesity and extended health complications and causes such as
Cardiovascular Disorder (CVD) for atherogenic dyslipidemia and
diabetes for insulin resistance on abdominal obesity as multiple
metabolic risk factors. Prior to using genomics based analytical tools,
analytic platform consist of several modules based on target molecules
with various disciples of the study of Omics categories including
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Proteomics, Transcriptomics, Metabolomics, Cellomics, Lipidomics,
Glycomics, Phamcogenomics, Neurogenetics and Nutrigenomics
[13,14]. The output give us a better understanding of what metabolic
syndromes are related to the development of disease pathogenesis in
molecular levels such as obesity in which risk factors in network/cluster
of molecules may interrupt by triggers (stressors) result from internal
and external factors in various sources like environmental, genetic,
and metabolic. Among them, neurogenetics and nutrigenomics are
considered to describe which part of brain would modify stimulus to
intake bad foods (poor nutrition) as energy resources or expenditure
to resist or survival along with molecular networks in several organ
interactions under brain circuits. Those omics approach may lead
to provide solutions which brain circuit or interaction molecule
network in the food and receptors on the tissue or organ while stress
stimulate take food more as compensatory mechanism. To visualize
an improved detection system in the tissue and monitoring brain
reward cascade between brain and adipose tissue, better and earlier
diagnostic tools such as Omics oriented strategy make a chance for
success in treatment or provide personalized therapy for individuals.
Nutrigenomics is a study of the role of nutrients on how gene
expression could be benefit to understand the cause of obesity and
to determine underlying factors associated with various metabolic
diseases due to molecular dysfunction in the mice and human body
[15,16]. By using new technologies in the field of Omics, we can
better visualize the molecular roadmap in metabolic diseases and
gain better solutions by establishing a higher degree of dimensionality
to understand the various deleterious effects of outside influences
(treatment). Moreover, it gives us a better direction in risk management
such as how food contamination from bacterial infection or food
ingredients, chemical preservatives becomes oxidative stressors to
defer impairment of homeostatic networks including the interruption
of brain reward with specific dopaminergic receptor and abnormal
metabolic cascade causing insulin resistance [17].
Oxidative stress occurs when cellular repair systems cannot
readily detoxify ROS. Although ROS generation occurs during
normal cellular metabolism within the mitochondria to generate
energy, oxidative stress occurs when there is an imbalance of redox
system which may lead to ROS-mediated toxicity linked damage
with a variety of biological macromolecules includes lipid, DNA,
and protein. Concordantly, ROS are key initiators of cellular
signaling cascades that lead to various metabolic disorders such as
Insulin Resistance (IR) and fasting hyperinsulinemia, which may
be associated with mitochondrial dysfunction and oxidative stress
[18]. Similar studies have indicated that the oxidative stress (i.e.,
ROS and RNS) produced by exogenous or endogenous factors
influences complex dynamics of human behavior associated with
health disparities like lack of vitamin D and exercise which should be
of primary concern pertaining to endothelial dysfunction, systemic
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inflammation, and chronic hypertension by epigenetic and posttranslational modification [19-24]. Nutrigenomic and epigenetic
studies are such a double-edged sword of discovery tool which
generally focuses on dietary patterns according to genetic variations,
the role of gene-nutrient interactions, gene-diet-phenotype
interactions and epigenetic modifications caused by nutrients; these
molecular tools will facilitate an understanding of the early molecular
events that occur in diabetes and will contribute to the identification
of better biomarkers and diagnostics tools. Omics approach could
help to develop tailored diets that maximize the use of nutrients and
cumulated functional ingredients present in good food, which should
be treating aberrant adipose-like stem cell in the prevention Obese
and delay of diabetes associated with other health complications.
In the future era, we consider that omics trial equipped with
molecule based tools by stratification such as nutrigenomics,
metabolomics, and neurogenetic research promises to discover a
key knowledge of biological function which molecules may involve
the pathogenesis network or compulsory individual response to
diet pattern in alteration of brain circuit, which is also important to
monitor environmental factors that interacts with molecule regulator
such as microRNA in epigenetic area could lead to modulate disease
risk [25-29]. A clear understanding of these interactions may drive
to support the concept of disease prevention through stratification
of risk pattern in personal medicine as well as optimization of
dietary recommendations. Current research progress has been
started to provide a resolution rapidly in the metabolic disorders
including obesity, where specific targeted nutritional advice, such as a
Mediterranean diet, helps to decrease cardiovascular risk factors and
stroke incidence in people with polymorphisms strongly associated
with type 2 diabetes. Omics is impacted to promote greater innovation,
which encompass harness of stress from the environment to prevent
metabolic disorders as well as improve quality of life with the health
of food through different angles of approaches equipped with new
detection modules such as protein array, NGS, metagenome, which
will provide a framework for the development of genome-dependent
food control for health brain reward strategies and the personalized
approaches for the prevention and management of diabetes mellitus,
stroke and CVD in public health.
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